Significance of metaphase II human oocyte morphology on ICSI outcome

Fertil Steril. 2008 Nov;90(5):1692-700. doi: 10.1016/j.fertnstert.2007.09.024. Epub 2008 Feb 4.

Abstract

Objective: To evaluate the influence of specific oocyte morphologic features (morphotypes) on intracytoplasmic sperm injection (ICSI) outcome. The identification of oocyte quality markers is particularly important when a low number of oocytes can be used for IVF.

Design: Retrospective analysis.

Setting: Medical center.

Patient(s): Five hundred sixteen consecutive ICSI cycles. Only couples affected by severe male factor infertility were excluded.

Intervention(s): A total of 1,191 metaphase II (MII) oocytes (1-3 per patient) were randomly selected from the cohort of oocytes obtained from each patient and evaluated for morphologic appearance.

Main outcome measure(s): Fertilization, pronuclear morphology, embryo quality, pregnancy rate.

Result(s): There was a presence of vacuoles, abnormal I polar body, and large perivitelline space related to a lower fertilization rate. Pronuclear morphology was effected by the presence of a large perivitelline space, diffused cytoplasmic granularity, and/or centrally located granular area. The latter characteristic also negatively related to day 2 embryo quality. According to the odds ratios obtained for each oocyte morphotype to reach at least one outcome, an MII oocyte morphologic score (MOMS) was calculated. A significant relationship was found between MOMS and female age, female basal FSH, and clinical outcome.

Conclusion(s): Morphologic evaluation before ICSI helps to identify MII oocytes with higher developmental potential.

MeSH terms

  • Adult
  • Age Factors
  • Cell Nucleus Shape
  • Cell Shape*
  • Cytoplasmic Granules / pathology
  • Embryo Implantation*
  • Female
  • Follicle Stimulating Hormone / blood
  • Humans
  • Infertility / metabolism
  • Infertility / pathology
  • Infertility / therapy*
  • Male
  • Metaphase*
  • Middle Aged
  • Oocytes / pathology*
  • Pregnancy
  • Pregnancy Rate
  • Retrospective Studies
  • Sperm Injections, Intracytoplasmic*
  • Treatment Outcome
  • Vacuoles / pathology
  • Vitelline Membrane / pathology
  • Young Adult

Substances

  • Follicle Stimulating Hormone